Narus Financial Partners, LLC

Position in LLY — ELI LILLY & Co

CIK 1698091 SALT LAKE CITY, UT

Position in LLY

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$524,150

+$72,543 QoQ

Shares Held

437

-11.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.23%

of 13F equity value

Holder Rank

#3,722

of 4,605 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Narus Financial Partners, LLC holds $2,295,659 across 6 Drug Manufacturers - General names. LLY ranks #2 (22.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	2,388	$600,916
2	LLY	ELI LILLY & Co This page	437	$524,150
3	BMY	Bristol Myers Squibb Co	6,636	$382,366
4	NVS	Novartis AG	1,889	$296,044
5	JNJ	Johnson & Johnson	1,024	$260,065
6	AMGN	Amgen Inc	641	$232,118

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$524,150	437	-11.0%	Shares	Sole	2026-07-31
2026-03-31	$451,607	491	-0.2%	Shares	Sole	2026-04-21
2025-12-31	$528,742	492	+23.3%	Shares	Sole	2026-02-09
2025-09-30	$304,437	399	—	Shares	Sole	2026-02-09
No filing history on record for this holder in this stock.